Continuum of Care for Opioid Use Disorder in Medicaid Recipients - Top-Institutions - MDSpire

Continuum of Care for Opioid Use Disorder in Medicaid Recipients

  • By

  • Thanh T. Lu

  • William N. Dowd

  • Tami L. Mark

  • Marianne Kluckman

  • Barrett Wallace Montgomery

  • Chelsea Katz

  • Dylan E. DeLisle

  • Gary A. Zarkin

  • April 22, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Addiction Medicine
    • Health Policy
    • Epidemiology

  • #2

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Addiction Psychiatry
    • Health Services Research

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Addiction Medicine
    • Public Health
    • Health Policy

  • #4

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, NY

    Key Differentiators

    • Addiction Psychiatry
    • Epidemiology
    • Health Policy

  • #5

    University of Michigan
    University of Michigan

    Ann Arbor, MI

    Key Differentiators

    • Addiction Medicine
    • Health Services Research

Original Source(s)

Continuum of Care for Opioid Use Disorder in Medicaid Recipients

  • by Thanh T. Lu, William N. Dowd, Tami L. Mark, Marianne Kluckman, Barrett Wallace Montgomery, Chelsea Katz, Dylan E. DeLisle, Gary A. Zarkin

  • April 22, 2026

Related Content

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Digital Twin Model May Improve Alcohol Intake Reconstruction

Integrated biomarker framework supports evaluation of drinking scenarios in forensic settings

Fentanyl Is Not a WMD